001     282329
005     20251121165837.0
024 7 _ |a 10.1101/2025.11.14.25340228
|2 doi
037 _ _ |a DZNE-2025-01290
100 1 _ |a Mantey, Richard
|0 P:(DE-2719)9002176
|b 0
|e First author
245 _ _ |a Tandem Repeat Polymorphisms Are Associated with Brain Structure: Results of Two Large Population-based Studies
260 _ _ |c 2025
336 7 _ |a Preprint
|b preprint
|m preprint
|0 PUB:(DE-HGF)25
|s 1763740624_6326
|2 PUB:(DE-HGF)
336 7 _ |a WORKING_PAPER
|2 ORCID
336 7 _ |a Electronic Article
|0 28
|2 EndNote
336 7 _ |a preprint
|2 DRIVER
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a Output Types/Working Paper
|2 DataCite
520 _ _ |a Although genome-wide association studies (GWAS) have uncovered many genetic variants linked to brain structure, much of its heritability remains unexplained. Short tandem repeats (STRs), which are rarely considered in GWAS, may contribute to this “missing heritability”. Using targeted deep sequencing, we systematically assessed the relationship between ∼3000 polymorphic STRs and brain imaging-derived phenotypes across 2958 participants of the Rhineland Study. Expansion of an intronic CA repeat in PRR14L was associated with larger thalamic volume (standardized β [95% CI]=0.15 [0.06–0.24]), while AATG repeat polymorphisms in NADK were associated with reduced subcortical gray matter volume (–0.05 [–0.08 to –0.01]). Both associations replicated in the UK Biobank cohort (N=38879). Beyond single loci, higher polygenic burden of moderate STR expansions was associated with increased total brain, gray matter, supratentorial, and thalamic volumes. Our findings indicate that moderate STR expansions are region-specific determinants of brain morphology and suggest that STR variability may have evolved to enhance neuroanatomical plasticity and cognitive function.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
536 _ _ |a TRANSIT-ND - Tandem Repeats Associated with Neurogenomic Somatic Instability and Neurodegeneration (101041677)
|0 G:(EU-Grant)101041677
|c 101041677
|f ERC-2021-STG
|x 1
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 2
588 _ _ |a Dataset connected to DataCite
693 _ _ |0 EXP:(DE-2719)PRECISE-20190321
|5 EXP:(DE-2719)PRECISE-20190321
|e Platform for Single Cell Genomics and Epigenomics at DZNE University of Bonn
|x 0
700 1 _ |a Hu, Jialu
|0 P:(DE-2719)9002875
|b 1
700 1 _ |a Touhidinia, Maryam
|0 P:(DE-2719)9002791
|b 2
700 1 _ |a Butt, Tanzeem
|0 P:(DE-2719)9003488
|b 3
700 1 _ |a Sidky, Ahmed Mokhtar
|0 P:(DE-2719)9003532
|b 4
700 1 _ |a Sobhani, Roohollah
|0 P:(DE-2719)9002351
|b 5
700 1 _ |a Estrada, Santiago
|0 P:(DE-2719)2812449
|b 6
700 1 _ |a Haendler, Kristian
|0 P:(DE-2719)2812735
|b 7
700 1 _ |a De Domenico, Elena
|0 P:(DE-2719)9000846
|b 8
700 1 _ |a Beyer, Marc D.
|0 P:(DE-2719)2812219
|b 9
700 1 _ |a Breteler, Monique M. B.
|0 P:(DE-2719)2810403
|b 10
700 1 _ |a Aziz, N. Ahmad
|0 P:(DE-2719)2812578
|b 11
|e Last author
773 _ _ |a 10.1101/2025.11.14.25340228
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9002176
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002875
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002791
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9003488
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9003532
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9002351
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2812449
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2812735
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9000846
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2812219
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810403
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2812578
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 1
914 1 _ |y 2025
920 1 _ |0 I:(DE-2719)5000071
|k AG Aziz
|l Population & Clinical Neuroepidemiology
|x 0
920 1 _ |0 I:(DE-2719)1012001
|k AG Breteler
|l Population Health Sciences
|x 1
920 1 _ |0 I:(DE-2719)1013035
|k AG Beyer
|l Immunogenomics and Neurodegeneration
|x 2
920 1 _ |0 I:(DE-2719)1040310
|k AG Reuter
|l Artificial Intelligence in Medicine
|x 3
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 4
980 _ _ |a preprint
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)5000071
980 _ _ |a I:(DE-2719)1012001
980 _ _ |a I:(DE-2719)1013035
980 _ _ |a I:(DE-2719)1040310
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21